Website stats and analysis

This  presentation was new, inspiring, informative educational and challenging. It has opened up new vistas for  education in general, and for remote/virtual learning in particular. It has made an "old " teacher young or rather "Younger" again. I feel as enthusiastic as when I first started teaching, many moons ago.

2.48 Rating by Usitestat

keynote180.com was registered 6 years 2 months ago. It has a alexa rank of #5,936,123 in the world. It is a domain having .com extension. It is estimated worth of $ 240.00 and have a daily income of around $ 1.00. As no active threats were reported recently, keynote180.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 148
Daily Pageviews: 296

Estimated Valuation

Income Per Day: $ 1.00
Estimated Worth: $ 240.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 5,936,123
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

185.230.63.107

Hosted Country:

United States US

Location Latitude:

39.0341

Location Longitude:

-77.4885

Search Engine Results For keynote180.com

Teacher Training | Keynote 180

- https://www.keynote180.com/

Teacher Training | Online Teaching | Leadership Training | Keynote 180 | Professional Development


Efficacy and Safety of Pembrolizumab for Heavily ...

- https://jamanetwork.com/journals/jamaoncology/fullarticle/2718411

Apr 01, 2019 · The KEYNOTE-180 study is a global, open-label, phase 2 study of pembrolizumab for patients with histologically confirmed advanced and metastatic esophageal...


FDA approves pembrolizumab for advanced esophageal ...

- https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-advanced-esophageal-squamous-cell-cancer

KEYNOTE-181 was a randomized, open-label, active-controlled trial that enrolled 628 patients with recurrent locally advanced or metastatic esophageal cancer who progressed on or...


Updated Analysis From KEYNOTE-189: Pembrolizumab or ...

- https://pubmed.ncbi.nlm.nih.gov/32150489/

First-line pembrolizumab plus pemetrexed-platinum continued to demonstrate substantially improved OS and PFS in metastatic nonsquamous NSCLC, regardless of PD-L1 expression or...


Study of Pembrolizumab (MK-3475) in Previously-Treated ...

- https://www.clinicaltrials.gov/ct2/show/NCT02559687

Sep 24, 2015 · Study of Pembrolizumab (MK-3475) in Previously-Treated Participants With Advanced Carcinoma of the Esophagus or Esophagogastric Junction (MK-3475-180/KEYNOTE-180)...


Efficacy of Pembrolizumab in Patients With Noncolorectal ...

- https://pubmed.ncbi.nlm.nih.gov/31682550/

Our study demonstrates the clinical benefit of anti-programmed death-1 therapy with pembrolizumab among patients with previously treated unresectable or metastatic MSI-H/dMMR...


Pembrolizumab versus chemotherapy as second-line therapy ...

- https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.4_suppl.2

2 Background: Patients with advanced esophageal cancer after first-line chemotherapy (chemo) have a poor prognosis and limited treatment options. We present results of the phase...


Team Development | Keynote 180

- https://www.keynote180.com/team-development

CALL: +1-973-531-READ (7323) [email protected]. Teacher Training. Team Development. Youth Leadership. Articles & Interviews. More. Dr. H. M. Saleem. Dr. H. M. Saleem has...


LEVEL II PAYPAL | Keynote 180

- https://www.keynote180.com/level-ii-paypal

CALL: +1-973-531-READ (7323) [email protected] Teacher Training. Team Development


Keynote 180 - Home | Facebook

- https://www.facebook.com/keynote180Topics/

Keynote 180, Woodbridge, New Jersey. 44 likes · 1 talking about this. On this page, Dr. Saleem discusses personal and professional issues of contemporary concerns to help us...


Keynote 180 with Dr. Saleem • A podcast on Anchor

- https://anchor.fm/keynote180

Spotify. Episode #102: Our Culture of Conspiracy Theories


twitter.com

- https://twitter.com/keynote180

We would like to show you a description here but the site won’t allow us.


Pembrolizumab Approved for Esophageal Cancer - National ...

- https://www.cancer.gov/news-events/cancer-currents-blog/2019/pembrolizumab-esophageal-fda-approval

KEYNOTE-180 was a phase 2 clinical trial that enrolled 121 patients with advanced, metastatic esophageal cancer that had progressed after two or more lines of standard therapy....


Pembrolizumab for patients with previously treated ...

- https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.4049

4049 Background: Effective therapy for patients (pts) with metastatic esophageal cancer progressing after at least 2 lines of prior therapy is an unmet need. The phase 2,...


KEYNOTE-181: Phase 3, open-label study of second-line ...

- https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.TPS4140

TPS4140 Background: Tumors can hijack the PD-1 pathway to suppress immune control. Overexpression of the PD-1 ligand PD-L1 in esophageal cancer may be associated with a poor...


Efficacy of Pembrolizumab in Patients With Noncolorectal ...

- https://pubmed.ncbi.nlm.nih.gov/31682550/

Our study demonstrates the clinical benefit of anti-programmed death-1 therapy with pembrolizumab among patients with previously treated unresectable or metastatic MSI-H/dMMR...


KEYNOTE-181研究亮相2019 ASCO-GI,PD-1单抗首次为晚期食管 …

- http://www.liangyihui.net/doc/47911

基于keynote-028和keynote-180研究中帕博利珠单抗显示的食管癌治疗前景,研究者进一步开展了iii期keynote-181研究,在晚期或转移性食管鳞癌或腺癌/siewert i型食管胃结合部腺癌患者的二线治疗中,头对头比较帕博利珠单抗与研究者选择的化疗。


KEYNOTE-181: Pembrolizumab vs chemotherapy in patients ...

- https://www.sciencedirect.com/science/article/pii/S0923753419578012

Nov 01, 2019 · ABSTRACTS Gastrointestinal tumours, non-colorectal 124O KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC)...


Shah Discusses KEYNOTE-180 and BRIGHTER Results in GI ...

- https://www.targetedonc.com/view/shah-discusses-keynote180-and-brighter-results-in-gi-cancers

TARGETED ONCOLOGY:Please provide some background to the KEYNOTE-180 trial. Shah:Esophageal cancer is a deadly disease. Unfortunately, most patients with metastatic disease die...


Antitumor activity and safety of pembrolizumab in patients ...

- https://pubmed.ncbi.nlm.nih.gov/31046082/

Background: Advanced recurrent ovarian cancer (ROC) is the leading cause of gynecologic cancer-related death in developed countries and new treatments are needed. Previous...


Study of Pembrolizumab (MK-3475) Versus Investigator's ...

- https://clinicaltrials.gov/ct2/show/NCT02564263

Sep 30, 2015 · In this study, participants with advanced or metastatic adenocarcinoma or squamous cell carcinoma of the esophagus or Siewert type I adenocarcinoma of the...

Page Resources Breakdown

Homepage Links Analysis

Teacher Training | Keynote 180
Teacher Training | Online Teaching | Leadership Training | Keynote 180 | Professional Development

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 19
H3 Headings: 3 H4 Headings: Not Applicable
H5 Headings: 4 H6 Headings: 1
Total IFRAMEs: 3 Total Images: 27
Google Adsense: Not Applicable Google Analytics: UA-172811670-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
Online Teaching 7 0.971 % No
LEVEL I 3 0.416 % No
student feedback 3 0.416 % No
Play Video 3 0.416 % No
Shall I 3 0.416 % No
to engage 3 0.416 % No
online teaching 3 0.416 % No
How to 3 0.416 % No
Effective Online 3 0.416 % No
Dr Saleem 2 0.277 % No
Teaching The 2 0.277 % No
LEVEL II 2 0.277 % No
for students 2 0.277 % No
Do I 2 0.277 % No
How Do 2 0.277 % No
Optional LEVEL 2 0.277 % No
Keynote 180 2 0.277 % No
For Effective 2 0.277 % No
has been 2 0.277 % No
And The 2 0.277 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
Playing WTSD LIVE Interactive 2 0.277 % No
WTSD LIVE Interactive Workshop 2 0.277 % No
Now Playing WTSD LIVE 2 0.277 % No
For Effective Online Teaching 2 0.277 % No
engaging online lessons Lecture 2 0.277 % No
Effective Online Teaching Learning 2 0.277 % No
tutorials on online teaching 2 0.277 % No
Tools Shall I Use 2 0.277 % No
Dr H M Saleem 2 0.277 % No
certification programs Networking with 1 0.139 % No
programs Networking with other 1 0.139 % No
Networking with other online 1 0.139 % No
and certification programs Networking 1 0.139 % No
workshops and certification programs 1 0.139 % No
teaching workshops and certification 1 0.139 % No
conferences Inschool or indistrict 1 0.139 % No
technology conferences Inschool or 1 0.139 % No
with other online teachers 1 0.139 % No
Online teaching workshops and 1 0.139 % No
via established technology educational 1 0.139 % No

Websites Hosted on Same IP (i.e. 185.230.63.107)

Woodend Building Design | Architect | Woodend

- wbdg.com.au

Woodend Building Design is an architectural design service, specialising in custom home designs. We work with you to design the project of your dreams.

  Not Applicable   $ 8.95

Knowledge Bridge Occasions | Continuing education for...

- knowl-bridge.com

Sure, here’s a site description for Google: Knowledge Bridge offers specialized continuing education and career advancement courses for physiotherapists and physical therapists...

  Not Applicable   $ 8.95

Kitchen Remodeling | YDY Professional Construction LLC | Tampa Florida

- ydyconstruction.com

At YDY Professional Construction, we understand that your home is more than just a place to live it's a reflection of your personal style and the backdrop for your daily life....

  Not Applicable   $ 8.95

Top Commercial Cleaning Services & Janitorial Services in Rhode...

- rhodeislandcleaningservice.com

Discover top-notch commercial cleaning services & janitorial services in Rhode Island. Quality, honesty, and efficiency guaranteed! Contact us at 401-402-0110 for a free...

  Not Applicable   $ 8.95

Vertu Wash | Mobile & Eco-Friendly Car Wash & Detailing Service,...

- vertuwash.ca

Vertu Wash, Vancouver's Mobile & Eco-Friendly Car Wash & Detailing Service. We Wash & Detail Your Car at Your Location Without Harming the Environment. Your Car Has Never Been...

  Not Applicable   $ 8.95

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Tue, 12 Jan 2021 10:48:36 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"f49177cada8bc9017c92fc0edf2ee046"
content-language: en
strict-transport-security: max-age=120
Age: 14
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=euw3
X-Seen-By: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVhfLb 9T2QrpEWFZU3uVkkF,2d58ifebGbosy5xc FRalrsg3cgHAIKuh6BO6XvxT8tS8rCgDKHmsD7QeMlrbMusjoe2GMQJ/MdiMK4Y/vI701lTh/5zgYzd1vtz2Udx9QQ=,2UNV7KOq4oGjA5 PKsX47GdUQGSP799Up94xsjyCJblWd3xniMsr1HjrszKGvMzr
Expires: Thu, 01 Jan 1970 00:00:00 GMT
Vary: Accept-Encoding
X-Wix-Request-Id: 1610448516.26517902907612667
cache-control: private,max-age=0,must-revalidate
Server: Pepyaka/1.19.0
Content-Encoding: gzip

Domain Information

Domain Registrar: GoDaddy.com, LLC
Registration Date: 2018-09-05 6 years 2 months 2 weeks ago
Last Modified: 2020-09-05 4 years 2 months 2 weeks ago

Domain Nameserver Information

Host IP Address Country
ns6.wixdns.net 216.239.32.100 United States United States
ns7.wixdns.net 216.239.34.100 United States United States

DNS Record Analysis

Host Type TTL Extra
keynote180.com A 3480 IP: 185.230.63.186
keynote180.com A 3480 IP: 185.230.63.107
keynote180.com A 3480 IP: 185.230.63.171
keynote180.com NS 86400 Target: ns6.wixdns.net
keynote180.com NS 86400 Target: ns7.wixdns.net
keynote180.com SOA 3600 MNAME: ns6.wixdns.net
RNAME: support.wix.com
Serial: 2018092304
Refresh: 10800
Retry: 3600
Expire: 604800
keynote180.com MX 3600 Priority: 50
Target: alt4.aspmx.l.google.com
keynote180.com MX 3600 Priority: 10
Target: aspmx.l.google.com
keynote180.com MX 3600 Priority: 20
Target: alt1.aspmx.l.google.com
keynote180.com MX 3600 Priority: 30
Target: alt2.aspmx.l.google.com
keynote180.com MX 3600 Priority: 40
Target: alt3.aspmx.l.google.com
keynote180.com TXT 3600 TXT:
google-site-verification=upkNIeiPwE5Gyg_
GEjpu-CHh18JPPSn3fB-TqByWcpQ

Full WHOIS Lookup

Domain Name: KEYNOTE180.COM
Registry Domain ID:
2306267493_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2020-09-05T15:47:35Z
Creation Date:
2018-09-05T03:43:04Z
Registry Expiry Date:
2022-09-05T03:43:04Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS6.WIXDNS.NET
Name Server: NS7.WIXDNS.NET
DNSSEC:
unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:
https://www.icann.org/wicf/
>>> Last update of whois database:
2021-01-12T10:49:52Z

Similarly Ranked Websites

Info-Pflege.de - Ihr Portal für Altenpflege und Krankenpflege |...

- info-pflege.de

Info-Pflege.de - Ihr Portal für Altenpflege und Krankenpflege Info-Pflege.de: Ihr Info-Portal für die Pflegedienste und Altenpflege und Krankenpflege: Info-Pflege: Das Portal...

5,936,156   $ 240.00

Yada Assessment | Yada.com

- yada.com

Your personal roadmap to incredible relationships with your friends, family, roommates, teammates and potential soulmate. Discover the Science of You.

5,936,221   $ 240.00

Etsi yrityksiä, tuotteita ja B-to-B-palveluja kansainvälisellä...

- europages.fi

Tutustu toimittajien, jakelijoiden ja valmistajien uusimpiin katalogeihin EUROPAGES-sivustolla.

5,936,300   $ 240.00

David M. Freedman, Financial and Legal Journalist, Writer - Chicago

- freedman-chicago.com

Chicago writer, author, journalist David M. Freedman. Focusing on finance, law, equity crowdfunding, woodworking, box-making, angel investing, great lakes highland park

5,936,362   $ 240.00

CSB | Calgary Signs Company | 3D LED Signage, Decals, Banners,...

- calgarysignsbanners.com

Shop for any type of sign for business, office, informational, promotional, safety, retail, street advertising, also vehicle decals, trade-show displays, banners, and more.

5,936,380   $ 240.00